About this episode
This episode of Essential unpacks FDA confusion, California’s latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC’s advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA’s eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere. News item about California reg: https://a4pc.org/news/this-one-little-word-could-trip-you-up Compounding primer: https://join.a4pc.org/hubfs/PDFs/Traditional-Pharmacy-Compounding-101.pdf?hsLang=en APC’s guide to hosting a legislator: https://join.a4pc.org/hubfs/PDFs/2021-04_APC-Guidance-Hosting-Pharmacy-Visits.pdf APC in the News: https://a4pc.org/inthenews DTE grassroots campaign: https://compounding.com/thyroid